This post lists nine key quotes from a San Francisco talk by Demis Hassabis and Sebastian Mallaby covering everything from OpenAI’s 50% bankruptcy risk to the need for new “AlphaFold” moments in drug discovery. They debate AGI probabilities, frontier cyber defense access, global AI optimism, and the economic and philosophical challenges of a post-scarcity future.

AWS introduced Amazon Bio Discovery, an AI-driven platform that lets researchers run complex drug-design workflows without coding. It provides a library of biological foundation models, an AI agent for workflow setup and analysis, and links to lab partners for synthesis and testing, cutting months of work down to weeks.